000 01616 a2200469 4500
005 20250517154108.0
264 0 _c20180412
008 201804s 0 0 eng d
022 _a1952-4013
024 7 _a10.1684/ejd.2017.2986
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIngen-Housz-Oro, Saskia
245 0 0 _aImmediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients.
_h[electronic resource]
260 _bEuropean journal of dermatology : EJD
_cJun 2017
300 _a271-274 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibiotics, Antineoplastic
_xadverse effects
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypersensitivity, Immediate
_xchemically induced
650 0 4 _aLymphoma, T-Cell, Cutaneous
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolyethylene Glycols
_xadverse effects
650 0 4 _aPremedication
650 0 4 _aSkin Neoplasms
_xdrug therapy
700 1 _aPham-Ledard, Anne
700 1 _aBrice, Pauline
700 1 _aLebrun-Vignes, Bénédicte
700 1 _aZehou, Ouidad
700 1 _aReitter, Delphine
700 1 _aRam-Wolff, Caroline
700 1 _aDupin, Nicolas
700 1 _aBagot, Martine
700 1 _aChosidow, Olivier
700 1 _aBeylot-Barry, Marie
773 0 _tEuropean journal of dermatology : EJD
_gvol. 27
_gno. 3
_gp. 271-274
856 4 0 _uhttps://doi.org/10.1684/ejd.2017.2986
_zAvailable from publisher's website
999 _c27190930
_d27190930